Mersana Therapeutics
MRSN
MRSN
151 hedge funds and large institutions have $1.83B invested in Mersana Therapeutics in 2020 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 54 increasing their positions, 45 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
151
Holders Change
+16
Holders Change %
+11.85%
% of All Funds
2.68%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.11%
New
34
Increased
54
Reduced
45
Closed
18
Calls
$12.1M
Puts
$5.27M
Net Calls
+$6.78M
Net Calls Change
+$946K
Top Buyers
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$51.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$40.9M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$39.3M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$22.9M |
| 5 |
BlackRock
New York
|
+$19.6M |
Top Sellers
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$111M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$55M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$17M |
| 4 |
O
OrbiMed
New York
|
-$14.8M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$14.1M |
